Loading...
mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer
Among currently available vaccine strategies for cancer, nucleotide-based vaccination is an appealing treatment modality. Curevacs’ mRNA containing vaccines (RNActive®) combine the beneficial properties of sufficient antigen-expression, autologous immune-stimulation and a high flexibility with respe...
Na minha lista:
| Udgivet i: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4514038/ https://ncbi.nlm.nih.gov/pubmed/25483661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.29553 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|